{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:50:11Z","timestamp":1779256211381,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.msard.2020.102395","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T23:46:15Z","timestamp":1594511175000},"page":"102395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Increased cerebrospinal fluid YKL-40 levels are associated with disease severity of neuromyelitis optica spectrum disorders"],"prefix":"10.1016","volume":"45","author":[{"given":"Yuan","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Sha","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2716-3793","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2020.102395_bib0001","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/14789450.2019.1628643","article-title":"The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development","volume":"16","author":"Baldacci","year":"2019","journal-title":"Expert. Rev. Proteomics"},{"issue":"1","key":"10.1016\/j.msard.2020.102395_bib0002","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2353\/ajpath.2008.080045","article-title":"YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor","volume":"173","author":"Bonneh-Barkay","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.msard.2020.102395_bib0003","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","article-title":"In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases","volume":"7","author":"Bonneh-Barkay","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"Pt 4","key":"10.1016\/j.msard.2020.102395_bib0004","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/brain\/awv017","article-title":"Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes","volume":"138","author":"Canto","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2020.102395_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3389\/fneur.2018.00727","article-title":"Elevation of YKL-40 in the CSF of Anti-NMDAR encephalitis patients is associated with poor prognosis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Neurol."},{"issue":"Pt 4","key":"10.1016\/j.msard.2020.102395_bib0006","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis","volume":"133","author":"Comabella","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.msard.2020.102395_bib0007","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/1352458510392619","article-title":"Chitinase effects on immune cell response in neuromyelitis optica and. multiple sclerosis","volume":"17","author":"Correale","year":"2011","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2020.102395_bib0008","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00296-010-1727-4","article-title":"The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis","volume":"32","author":"Gungen","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"10","key":"10.1016\/j.msard.2020.102395_bib0009","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1177\/1352458514561906","article-title":"Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis","volume":"21","author":"Hinsinger","year":"2015","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2020.102395_bib0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/glia.22635","article-title":"Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures","volume":"62","author":"Howe","year":"2014","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.msard.2020.102395_bib0011","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2020.102395_bib0012","first-page":"92","article-title":"Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis","volume":"10","author":"Jafari-Nakhjavani","year":"2019","journal-title":"Caspian J. Intern. Med."},{"issue":"5","key":"10.1016\/j.msard.2020.102395_bib0013","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ana.22220","article-title":"Elevated plasma YKL-40. levels and ischemic stroke in the general population","volume":"68","author":"Kjaergaard","year":"2010","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2020.102395_bib0014","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"issue":"9451","key":"10.1016\/j.msard.2020.102395_bib0015","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"The Lancet"},{"issue":"1\u20132","key":"10.1016\/j.msard.2020.102395_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2014.02.004","article-title":"CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment","volume":"269","author":"Malmestrom","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.msard.2020.102395_bib0017","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/1352458514549397","article-title":"Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis","volume":"21","author":"Martinez","year":"2015","journal-title":"Mult. Scler."},{"issue":"45","key":"10.1016\/j.msard.2020.102395_bib0018","doi-asserted-by":"crossref","first-page":"44058","DOI":"10.1074\/jbc.M306792200","article-title":"Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation","volume":"278","author":"Rehli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.msard.2020.102395_bib0019","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpsychires.2018.07.014","article-title":"Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change","volume":"104","author":"Reus","year":"2018","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.msard.2020.102395_bib0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.25143","article-title":"Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis","volume":"83","author":"Thompson","year":"2018","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2020.102395_bib0021","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/00365520310000537","article-title":"Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease","volume":"38","author":"Vind","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.msard.2020.102395_bib0022","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102395_bib0023","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00264-009-0747-8","article-title":"Human cartilage glycoprotein 39\u2013biomarker of joint damage in knee osteoarthritis","volume":"33","author":"Zivanovic","year":"2009","journal-title":"Int. Orthop."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820304703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820304703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:50:59Z","timestamp":1761900659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820304703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":23,"alternative-id":["S2211034820304703"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102395","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased cerebrospinal fluid YKL-40 levels are associated with disease severity of neuromyelitis optica spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102395"}}